Goldman Sachs’s SPDR S&P Biotech ETF XBI Stock Holding History

Goldman Sachs’s Portfolio XBI Stock Details XBI Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.5B	Buy	18,096,835 +4,997,277	+38%	+$414M	0.2%	63
2025 Q1	$1.06B	Buy	13,099,558 +3,544,529	+37%	+$287M	0.17%	84
2024 Q4	$861M	Sell	9,555,029 -3,185,665	-25%	-$287M	0.14%	101
2024 Q3	$1.26B	Buy	12,740,694 +789,077	+7%	+$78M	0.2%	65
2024 Q2	$1.11B	Buy	11,951,617 +2,069,350	+21%	+$192M	0.19%	72
2024 Q1	$938M	Sell	9,882,267 -279,842	-3%	-$26.6M	0.17%	88
2023 Q4	$907M	Sell	10,162,109 -2,669,895	-21%	-$238M	0.17%	86
2023 Q3	$937M	Buy	12,832,004 +2,523,251	+24%	+$184M	0.2%	72
2023 Q2	$858M	Buy	10,308,753 +5,185,843	+101%	+$431M	0.18%	77
2023 Q1	$390M	Buy	5,122,910 +12,685	+0.2%	+$967K	0.09%	183
2022 Q4	$424M	Buy	5,110,225 +90,486	+2%	+$7.51M	0.1%	167
2022 Q3	$398M	Sell	5,019,739 -1,578,160	-24%	-$125M	0.1%	155
2022 Q2	$490M	Buy	6,597,899 +896,136	+16%	+$66.6M	0.12%	115
2022 Q1	$512M	Sell	5,701,763 -2,381,440	-29%	-$214M	0.11%	144
2021 Q4	$905M	Buy	8,083,203 +1,229,149	+18%	+$138M	0.18%	72
2021 Q3	$862M	Buy	6,854,054 +804,759	+13%	+$101M	0.18%	73
2021 Q2	$819M	Sell	6,049,295 -4,907,158	-45%	-$664M	0.18%	75
2021 Q1	$1.49B	Sell	10,956,453 -5,135,573	-32%	-$697M	0.37%	26
2020 Q4	$2.27B	Buy	16,092,026 +4,017,839	+33%	+$566M	0.58%	13
2020 Q3	$1.35B	Sell	12,074,187 -4,034,230	-25%	-$450M	0.38%	22
2020 Q2	$1.8B	Sell	16,108,417 -1,183,344	-7%	-$132M	0.55%	15
2020 Q1	$1.34B	Buy	17,291,761 +6,656,476	+63%	+$515M	0.47%	20
2019 Q4	$1.01B	Buy	10,635,285 +3,858,536	+57%	+$367M	0.26%	61
2019 Q3	$517M	Buy	6,776,749 +245,133	+4%	+$18.7M	0.15%	104
2019 Q2	$573M	Sell	6,531,616 -1,874,359	-22%	-$164M	0.16%	91
2019 Q1	$761M	Buy	8,405,975 +1,702,845	+25%	+$154M	0.23%	62
2018 Q4	$481M	Sell	6,703,130 -2,235,877	-25%	-$160M	0.15%	91
2018 Q3	$857M	Buy	8,939,007 +454,472	+5%	+$43.6M	0.22%	62
2018 Q2	$808M	Buy	8,484,535 +1,031,009	+14%	+$98.1M	0.22%	62
2018 Q1	$654M	Buy	7,453,526 +1,778,312	+31%	+$156M	0.17%	93
2017 Q4	$482M	Buy	5,675,214 +127,506	+2%	+$10.8M	0.12%	149
2017 Q3	$480M	Sell	5,547,708 -544,698	-9%	-$47.2M	0.12%	121
2017 Q2	$470M	Buy	6,092,406 +384,729	+7%	+$29.7M	0.12%	121
2017 Q1	$396M	Buy	5,707,677 +726,191	+15%	+$50.4M	0.11%	134
2016 Q4	$295M	Sell	4,981,486 -4,177,682	-46%	-$247M	0.08%	182
2016 Q3	$607M	Buy	9,159,168 +1,257,170	+16%	+$83.3M	0.18%	58
2016 Q2	$427M	Sell	7,901,998 -3,541,330	-31%	-$192M	0.14%	98
2016 Q1	$591M	Buy	11,443,328 +2,324,677	+25%	+$120M	0.19%	68
2015 Q4	$640M	Sell	9,118,651 -5,733,995	-39%	-$403M	0.2%	67
2015 Q3	$925M	Buy	14,852,646 +10,486,923	+240%	+$653M	0.31%	25
2015 Q2	$1.1B	Buy	4,365,723 +754,241	+21%	+$190M	0.34%	25
2015 Q1	$814M	Buy	3,611,482 +320,631	+10%	+$72.3M	0.26%	42
2014 Q4	$614M	Sell	3,290,851 -87,385	-3%	-$16.3M	0.19%	66
2014 Q3	$527M	Buy	3,378,236 +654,256	+24%	+$102M	0.17%	81
2014 Q2	$419M	Buy	2,723,980 +713,883	+36%	+$110M	0.13%	119
2014 Q1	$286M	Buy	2,010,097 +417,746	+26%	+$59.5M	0.09%	172
2013 Q4	$207M	Buy	1,592,351 +571,870	+56%	+$74.5M	0.07%	250
2013 Q3	$132M	Sell	1,020,481 -36,826	-3%	-$4.76M	0.05%	344
2013 Q2	$110M	Buy	+1,057,307	New	+$110M	0.04%	380